BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6381356)

  • 1. Ocular fluorophotometry in insulin-treated diabetic patients with and without retinopathy.
    Kjaergaard JJ; Ohrt V
    Int J Microcirc Clin Exp; 1983; 2(3):207-13. PubMed ID: 6381356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular fluorophotometry in normal subjects.
    Kjaergaard JJ
    Int J Microcirc Clin Exp; 1983; 2(3):199-205. PubMed ID: 6678847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential vitreous fluorophotometry in diabetes mellitus: a five-year prospective study.
    Waltman SR
    Trans Am Ophthalmol Soc; 1984; 82():827-49. PubMed ID: 6535330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of vitreous fluorophotometry to distinguish between diabetics with and without observable retinopathy: effect of vitreous abnormalities on the measurement.
    Prager TC; Chu HH; Garcia CA; Anderson RE; Field JB; Orzeck EA; Comstock JP
    Invest Ophthalmol Vis Sci; 1983 Jan; 24(1):57-65. PubMed ID: 6826315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The blood-ocular barrier in type I diabetes without diabetic retinopathy: permeability measurements using fluorophotometry.
    Schalnus R; Ohrloff C
    Ophthalmic Res; 1995; 27 Suppl 1():116-23. PubMed ID: 8577448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of abnormalities in ocular fluorophotometry in insulin-dependent diabetes after five to nine months of improved metabolic control.
    White NH; Waltman SR; Krupin T; Santiago JV
    Diabetes; 1982 Jan; 31(1):80-5. PubMed ID: 6759217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posterior vitreous fluorophotometry. II. Comparison of diabetic patients and controls with the use of a new analysis procedure.
    Roy MS; Bungay PM; Bonner RF
    Arch Ophthalmol; 1989 Sep; 107(9):1328-33. PubMed ID: 2675803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitreous fluorophotometry in patients with no or minimal diabetic retinopathy.
    Chahal P; Fallon TJ; Jennings SJ; Chowienczyk PJ; Kohner EM
    Diabetes Care; 1986; 9(2):134-9. PubMed ID: 3698779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic vitreous fluorophotometry in experimental diabetes.
    Jones CW; Cunha-Vaz J; Zweig KO; Stein M
    Arch Ophthalmol; 1979 Oct; 97(10):1941-3. PubMed ID: 485921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posterior vitreous fluorophotometry in diabetic patients with minimal or no retinopathy.
    Roy MS; Podgor MJ; Bungay P; Grunberger G; Carl J; Ellis D
    Retina; 1987; 7(3):170-6. PubMed ID: 3423432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of the blood-retinal barrier in experimental diabetes mellitus.
    Waltman S; Krupin T; Hanish S; Oestrich C; Becker B
    Arch Ophthalmol; 1978 May; 96(5):878-9. PubMed ID: 655925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of the clinical role of vitreous fluorophotometry.
    McCullough PC; Koester CJ; Campbell CJ; Anderson EA
    Trans Am Ophthalmol Soc; 1983; 81():130-48. PubMed ID: 6676966
    [No Abstract]   [Full Text] [Related]  

  • 13. Fluorophotometry in juvenile-onset diabetes: long-term follow-up.
    Krupin T; Waltman SR
    Jpn J Ophthalmol; 1985; 29(2):139-45. PubMed ID: 4046222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The blood-retinal barrier permeability in diabetic patients.
    Krogsaa B; Lund-Andersen H; Mehlsen J; Sestoft L; Larsen J
    Acta Ophthalmol (Copenh); 1981 Oct; 59(5):689-94. PubMed ID: 7315223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A follow-up study by vitreous fluorophotometry of early retinal involvement in diabetes.
    Cunha-Vaz JG; Fonseca JR; Abreu JF; Ruas MA
    Am J Ophthalmol; 1978 Oct; 86(4):467-73. PubMed ID: 707592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihistamines reduce blood-retinal barrier permeability in type I (insulin-dependent) diabetic patients with nonproliferative retinopathy. A pilot study.
    Gardner TW; Eller AW; Friberg TR; D'Antonio JA; Hollis TM
    Retina; 1995; 15(2):134-40. PubMed ID: 7624601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping retinal fluorescein leakage with confocal scanning laser fluorometry of the human vitreous.
    Lobo CL; Bernardes RC; Santos FJ; Cunha-Vaz JG
    Arch Ophthalmol; 1999 May; 117(5):631-7. PubMed ID: 10326960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitreous fluorophotometry in adult-onset diabetes mellitus.
    Waltman SR; Krupin T; Kilo C; Becker B
    Am J Ophthalmol; 1979 Sep; 88(3 Pt 1):342-5. PubMed ID: 484662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term kinetic vitreous fluorophotometry in normal and diabetic subjects.
    Knudsen LL; Olsen T; Nielsen-Kudsk F
    Acta Ophthalmol (Copenh); 1992 Oct; 70(5):570-7. PubMed ID: 1471478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some aspects of the pharmacokinetics of fluorescein in normal and in diabetic subjects.
    Kjaergaard JJ; Dideriksen K; Mourits-Andersen T
    Int J Microcirc Clin Exp; 1983; 2(3):191-7. PubMed ID: 6678846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.